Literature DB >> 16246256

Inherited defects of coagulation Factor V: the thrombotic side.

H L Vos1.   

Abstract

DNA variations in the Factor V gene have played a major role in thrombosis research ever since the discovery of Factor V Leiden. Here, all relatively common DNA variations in the coding regions of the Factor V gene are discussed. Many of them have been associated with venous thrombosis or related diseases. However, most variations have been studied separately, without taking the presence of other variations in the same gene into account. This means that their association with disease should be interpreted with caution, as it may reflect linkage with another variation. An approach in which a haplotype-based analysis of the Factor V gene is combined with in vitro assays of recombinant proteins is advocated. Finally, a possible reason for the relatively polymorphic nature of the Factor V protein is discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16246256     DOI: 10.1111/j.1538-7836.2005.01572.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

1.  Platelets and platelet-derived factor Va confer hemostatic competence in complete factor V deficiency.

Authors:  Beth A Bouchard; John Chapin; Kathleen E Brummel-Ziedins; Peter Durda; Nigel S Key; Paula B Tracy
Journal:  Blood       Date:  2015-04-20       Impact factor: 22.113

2.  Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism.

Authors:  Olga V Gran; Erin N Smith; Sigrid K Brækkan; Hilde Jensvoll; Terry Solomon; Kristian Hindberg; Tom Wilsgaard; Frits R Rosendaal; Kelly A Frazer; John-Bjarne Hansen
Journal:  Haematologica       Date:  2016-06-16       Impact factor: 9.941

3.  Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  J Coagul Disord       Date:  2010-07-01

4.  A Novel Phenotype of the Factor 5 Gene Mutation (Homozygote Met1736Val and Heterozygote Asp68His) Is Associated With Moderate Factor V Deficiency.

Authors:  Yueh-Shih Chang; Yi-Cheng Lan; Ya-Jyun Chen; Jen-Seng Huang; Chia-Ning Yang; Chi-Ying F Huang; Kun-Yun Yeh
Journal:  Front Med (Lausanne)       Date:  2022-06-09

Review 5.  Rare congenital bleeding disorders.

Authors:  Massimo Franchini; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Francesca Masiello; Eva Veropalumbo; Vanessa Piccinini; Ilaria Pati; Liviana Catalano; Giancarlo Maria Liumbruno
Journal:  Ann Transl Med       Date:  2018-09

6.  Profiling the mutational landscape of coagulation factor V deficiency.

Authors:  Elvezia Maria Paraboschi; Marzia Menegatti; Valeria Rimoldi; Munira Borhany; Magy Abdelwahab; Donato Gemmati; Flora Peyvandi; Stefano Duga; Rosanna Asselta
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

7.  Combined effects of thrombosis pathway gene variants predict cardiovascular events.

Authors:  Kirsi Auro; Mervi Alanne; Kati Kristiansson; Kaisa Silander; Kari Kuulasmaa; Veikko Salomaa; Leena Peltonen; Markus Perola
Journal:  PLoS Genet       Date:  2007-06-07       Impact factor: 5.917

8.  Association of FV G1691A Polymorphism but not A4070G With Coronary Artery Disease.

Authors:  Ahmed Amara; Meriem Mrad; Aicha Sayeh; Abdeddayem Haggui; Dhaker Lahideb; Najiba Fekih-Mrissa; Habib Haouala; Brahim Nsiri
Journal:  Clin Appl Thromb Hemost       Date:  2017-11-27       Impact factor: 2.389

9.  Prevalence of rare F5 variants in general population from Bosnia and Herzegovina.

Authors:  Adna Ašić; Ramona Salazar; Niels Storm; Serkan Doğan; Wolfgang Höppner; Damir Marjanović; Dragan Primorac
Journal:  Mol Biol Rep       Date:  2021-07-02       Impact factor: 2.316

10.  Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm.

Authors:  Katarzyna Oszajca; Konrad Wroński; Grażyna Janiszewska; Małgorzata Bieńkiewicz; Michał Panek; Jacek Bartkowiak; Janusz Szemraj
Journal:  Exp Ther Med       Date:  2012-06-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.